These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Clinical and Histopathologic Characteristics Associated with Renal Outcomes in Lupus Nephritis. Rijnink EC, Teng YKO, Wilhelmus S, Almekinders M, Wolterbeek R, Cransberg K, Bruijn JA, Bajema IM. Clin J Am Soc Nephrol; 2017 May 08; 12(5):734-743. PubMed ID: 28473317 [Abstract] [Full Text] [Related]
4. Predictors of end-stage renal disease and recurrence of lupus activity after initiation of dialysis in patients with lupus nephritis. Moon SJ, Park HS, Kwok SK, Ju JH, Kim HY, Park SH. Clin Exp Rheumatol; 2013 May 08; 31(1):31-9. PubMed ID: 22935632 [Abstract] [Full Text] [Related]
5. Renal Remission Status and Longterm Renal Survival in Patients with Lupus Nephritis: A Retrospective Cohort Analysis. Davidson JE, Fu Q, Ji B, Rao S, Roth D, Magder LS, Petri M. J Rheumatol; 2018 May 08; 45(5):671-677. PubMed ID: 29496892 [Abstract] [Full Text] [Related]
11. Outcome in biopsy-proven Lupus nephritis: Evaluation of biopsies from the Norwegian Kidney Biopsy Registry. Norby GE, Mjøen G, Bjørneklett R, Vikse BE, Holdaas H, Svarstad E, Aasarød K. Lupus; 2017 Jul 08; 26(8):881-885. PubMed ID: 28059018 [Abstract] [Full Text] [Related]
12. Assessment of long-term remission in lupus nephritis patients: a retrospective analysis over 30 years. Fernandes das Neves M, Irlapati RV, Isenberg D. Rheumatology (Oxford); 2015 Aug 08; 54(8):1403-7. PubMed ID: 25725362 [Abstract] [Full Text] [Related]
13. Tubulointerstitial damage predicts end stage renal disease in lupus nephritis with preserved to moderately impaired renal function: A retrospective cohort study. Broder A, Mowrey WB, Khan HN, Jovanovic B, Londono-Jimenez A, Izmirly P, Putterman C. Semin Arthritis Rheum; 2018 Feb 08; 47(4):545-551. PubMed ID: 28803673 [Abstract] [Full Text] [Related]
14. Clinical, biochemical and pathological predictors of poor response to intravenous cyclophosphamide in patients with proliferative lupus nephritis. Conlon PJ, Fischer CA, Levesque MC, Smith SR, St Clair EW, Allen NB, Fleming JA, Howell DN. Clin Nephrol; 1996 Sep 08; 46(3):170-5. PubMed ID: 8879851 [Abstract] [Full Text] [Related]
15. Clinical characteristics and long-term outcomes in patients with mixed Class III/IV + V and pure proliferative lupus nephritis: A single-center experience. Ahn SS, Yoo J, Lee SW, Song JJ, Park YB, Jung SM. Lupus; 2022 Apr 08; 31(5):588-595. PubMed ID: 35316102 [Abstract] [Full Text] [Related]
16. The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases. Shen K, Yu Y, Tang Z, Liu Z, Li L. Chin Med J (Engl); 1997 Jul 08; 110(7):502-7. PubMed ID: 9594205 [Abstract] [Full Text] [Related]
17. Clinical and histological features of lupus nephritis in Japan: A cross-sectional analysis of the Japan Renal Biopsy Registry (J-RBR). Hiromura K, Ikeuchi H, Kayakabe K, Sugiyama H, Nagata M, Sato H, Yokoyama H, Nojima Y. Nephrology (Carlton); 2017 Nov 08; 22(11):885-891. PubMed ID: 27461874 [Abstract] [Full Text] [Related]
19. Renal response at 2 years post biopsy to predict long-term renal survival in lupus nephritis: a retrospective analysis of the Hopkins Lupus Cohort. Cooper Blenkinsopp S, Fu Q, Green Y, Madan A, Juliao P, Goldman DW, Roth DA, Petri MA. Lupus Sci Med; 2022 Aug 08; 9(1):. PubMed ID: 36038160 [Abstract] [Full Text] [Related]
20. Outcome of biopsy-proven lupus nephritis with low glomerular filtration rate at presentation. Haridasan S, Rathi M, Sharma A, Nada R, Kumar S, Ramachandran R, Kohli HS. Int J Rheum Dis; 2020 Aug 08; 23(9):1201-1209. PubMed ID: 32677761 [Abstract] [Full Text] [Related] Page: [Next] [New Search]